Abstract
An International Multicenter Study of Intravenous Bevacizumab for the Treatment of Chronic Bleeding and Anemia in Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bleed Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have